EDEN
PRAIRIE, Minn., May 3, 2022
/PRNewswire/ -- NeuroOne Medical Technologies Corporation
(NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology
company focused on improving surgical care options and outcomes for
patients suffering from neurological disorders, will host a
conference call to discuss financial results for its second quarter
of fiscal 2022, ended March 31, 2021, on May 12,
2022 at 4:30 PM Eastern Time.
Conference Call and Webcast Information:
May 12, 2022 – 4:30 PM Eastern Time
Participant Dial-In:
877-407-8293 / +1 201-689-8349
Live Webcast:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=MBrdTO6j
Phone Replay:
877-660-6853 / +1 201-612-7415, Access ID: 13729644; available
through May 26, 2022
Webcast Replay:
Available for 12 months
About NeuroOne® Medical Technologies Corporation
NeuroOne is a medical technology company focused on the
development and commercialization of minimally invasive and
high-definition/high-precision solutions for epilepsy, Parkinson's
disease, dystonia, essential tremors, and chronic pain due to
failed back surgeries. These solutions include electrodes that have
the potential to reduce the number of hospitalizations, surgical
procedures and cost while improving patient outcomes due to their
potential for offering combination diagnostic and therapeutic
functions such as EEG recording and tissue ablation and/or chronic
stimulation. A combination recording and RF ablation technology is
currently under development. In addition, NeuroOne is currently
testing its electrodes for long term stimulation. The Company is
also investigating the potential application of its technology for
artificial intelligence and machine learning. Visit n1mtc.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/neuroone-to-report-second-quarter-fiscal-year-2022-financial-results-on-may-12-301538336.html
SOURCE NeuroOne Medical Technologies Corporation